BRISBANE, Calif. — CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients, announces that it has signed an agreement with Illumina, Inc. (Nasdaq:ILMN) for the acquisition of Conexio SBT Resolver™ products and Assign™ SBT analysis software for high resolution HLA typing. SBT Resolver assay designs […]
The In-Fusion Cloning Primer Design Tool, powered by TeselaGen, generates primer sequences and vector maps Mountain View and San Francisco, CA—Takara Bio USA, Inc. (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., today announced the launch of the In-Fusion Cloning Primer Design Tool, powered by TeselaGen Biotechnology, Inc. software. In-Fusion […]
U.S. Patent and Trademark Office finds U.S. Patent No. 8,658,430 invalid in inter partes review PLEASANTON, Calif. – 10x Genomics, Inc. today announced that the company has prevailed in an inter partes review proceeding before the U.S. Patent and Trademark Office to invalidate U.S. Patent No. 8,658,430 owned by RainDance Technologies, Inc. 10x initiated the proceeding after […]
Acquisition brings unprecedented scale and speed to organism design BOSTON — Ginkgo Bioworks, the organism company, announced today the acquisition of Gen9, a pioneer in the synthesis and assembly of DNA. The acquisition will bring Gen9’s unique expertise in assembling pathway-length synthetic DNA into Ginkgo’s automated organism engineering foundries, enabling improved speed and capacity in the […]
New Two-Year Agreement with Belgian University to Focus on Detecting Genetic Abnormalities in Cell-free DNA and Embryo Biopsies SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that it is extending its collaboration with the Centre for Human Genetics of the University of Leuven and the University Hospital of Leuven in Belgium. Joris Vermeesch, […]
Mountain View, CA—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of Rubicon Genomics, Inc. (“Rubicon”), Rubicon has become a wholly-owned subsidiary of TBUSH as of January 17, 2017 (US local time). The Takara Bio Group provides a wide range of life science products and services under the Takara, Clontech, and […]
Renewal continues fundamental research into advanced biofuels Large team of researchers focused on Synthetic Genomics’ core synthetic biology technologies Progress continues toward development of algae-based transportation fuels LA JOLLA, Calif.—-Synthetic Genomics, Inc. and ExxonMobil (NYSE: XOM) announced today that they have extended their agreement to conduct joint research into advanced algae biofuels after making significant […]
Provides Fast, Easy Way for Seven Bridges Users to Access and Analyze Data Generated in Europe, under the Protection of EU Data Protection Regulations CAMBRIDGE, Mass. – Seven Bridges, the biomedical data analysis company, today announced that the Seven Bridges Platform is now live on the Amazon Web Services (AWS) EU (Frankfurt) Region in Frankfurt, Germany, […]
MENLO PARK, Calif. — Synthomics, Inc., an emerging developer of next-generation systems for oligonucleotide synthesis, announced today that it has completed seed round financing and has launched an early access program for its end-to-end DNA synthesis platform. The financing round was anchored by TEEC Angel Fund (http://www.teec-angel.com), a Palo Alto, CA-based Micro VC fund with an […]
Diagenode reinforces collaboration with the Heidelberg University Hospital and the German Cancer Research Center (DKFZ) for the development of a DNA amplification method for NGS library preparation Denville, NJ and Liege, Belgium Diagenode, a leading global provider for complete solutions for sample preparation and epigenetics research, recently announced a collaboration with the Heidelberg University Hospital […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
